1 / 64

INFECTIOUS DISEASES

INFECTIOUS DISEASES. ABDI SOLOMON(MD). Generally infectious diseases result from bacteria, viruses, fungi, and parasites . I nfectious diseases remain a major cause of death and are responsible for worsening the living conditions of many millions of people

tamira
Download Presentation

INFECTIOUS DISEASES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. INFECTIOUS DISEASES ABDI SOLOMON(MD)

  2. Generally infectious diseases result from bacteria, viruses, fungi, and parasites. • Infectious diseases remain a major cause of death and are responsible for worsening the living conditions of many millions of people • Infectious diseases often do not occur in isolated cases • Many factors affect the likelihood of acquiring infections which include, host, environment and microbial factors.

  3. Many factors affect the likelihood of acquiring infections which include • host • environment • Infectious agents.

  4. Host factor • Many specific host factors influence the likelihood of acquiring an infectious disease. • Age, immunization history, prior illnesses, level of nutrition, pregnancy, coexisting illness, and perhaps emotional state all have some impact on the risk of infection after exposure to a potential pathogen. • Defense-immunity-innate/adaptive

  5. Immune response: • Is a defense mechanism developed by the host for recognizing and responding to microorganisms. • two major classes. Innate and Acquired Immunity. Innate immunity (Natural Immunity) : • Is first line of defense and serves to protect the host with out prior exposure to the infectious agent. • is nonspecific and has no memory.eg phagocytosesby macrophages and nutrophils, complement system etc

  6. Acquired (Adaptive) Immunity: specific immune mechanism developed against a particular organism.takes long time to develop It has two major arms: .Cellular immunity: comprising T- lymphocytes, NK cells .Humeral Immunity : comprises of B-Lymphocytes and antibodies produced by plasma cells.

  7. Enviromental factors • Factors such as geography (e.g. altitude and malaria), environment (e.g. mosquito breeding site and malaria), disease vectors • Cleans of the environment • Over crowding

  8. Infectious agent • Viruses • Viruses contain two types of macromolecule: proteins and nucleic acids, the latter of only one type (either DNA or RNA). • Bacteria • Long known as 'prokaryotes', bacteria share the following essential features: they contain both RNA and DNA, have facilities for protein metabolism and are generally free living. • Eukaryotes • These organisms exhibit subcellular compartmentalisation with intracellular functions being achieved by specific organelles, e.g. nucleus, chloroplasts, mitochondria and Golgi apparatus.Fungi,Protozoa,parasites

  9. Incubation period: • The incubation period is the period between the invasion of the tissues by pathogens and the appearance of clinical features of infection. • The period of infectivity is the time that the patient is infectious to others

  10. Typhoid (Enteric) Fever • Definition: Typhoid fever is a systemic infection caused by dissemination of Salmonella typhi and occasionally by S. paratyphi A and B and S.typhimarium • non capsulated, gram negative motile and rod shaped bacteria. • Antigens: • H-located in the cell capsule H (flagellar antigen). • O- (Somatic or cell wall antigen). • Vi -(polysaccharide virulence) “widel test”

  11. A schematic diagram of a single Salmonella typhi cell showing the locations of the H (flagellar), 0 (somatic), and Vi (K envelope) antigens.

  12. Epidemiology • Continues to be a global health problem • Areas with a high incidence include Asia, Africa and Latin America • Affects about 6000000 people with more than 600000 deaths a year. 80% in Asia

  13. Transmission • fecal-oral route • close contact with patients or carriers • contaminated water and food • flies and cockroaches.

  14. Ingested orally • Stomach barrier (some Eliminated) • enters the small intestine Penetrate the mucus layer  enter mononuclear phagocytes of ilealpeyer's patches and mesenteric lymph nodes  proliferate in mononuclear phagocytes spread to blood. initial bacteremia (Incubation period). Pathogenesis

  15. Pathogenesis enter spleen, liver and bone marrow (reticulo-endothelial system) further proliferation occurs  A lot of bacteria enter blood again-(second bacteremia).  Recovery

  16. Bac. In gall Bac. In feces S.Typhi eliminated convalvescence stage (4-5w) peyer's patches & mesenteric lymph nodes S.Typhi. liver、spleen、gall、 BM ,ect early stage&acme stage (1-3W) 2nd bacteremia stomach (mononuclear phagocytes) Lower ileum 1st bacteremia (Incubation stage) 10-14d LN Proliferate,swell necrosis defervescence stage (3-4w) thoracic duct Enterorrhagia,intestinal perforation

  17. Clinical Manifestation • The incubation period varies from 3-60 days. • First week • Fever is high grade, with a daily increase in a step-ladder pattern for the 1st one week and then becomes persistent. • Headache , malaise , Abdominal pain • Initially diarrhea or loss stole followed by constipation in adults, diarrhea is dominate feature in children • Relative bradycardia • Splenomegally Hepatomegaly • “Rose spots”

  18. Second week • Fever becomes continuous • The patient becomes very ill and withdrawn confused, delirious and sometimes may be even comatose Third Week • • The patient goes to a pattern of “typhoidal state" characterized by extreme toxemia, • disorientation, and “pea-soup” diarrhea and sometimes may be complicated by intestinal perforation and hemorrhage.

  19. Fourth Week • Fever starts to decrease and the patient may deferveresce with resolution of symptoms. At this point patient may lose weight. • Relapse may occur in 10% of cases. • fatal complication • intestinal hemorrhage(serious blding 2-8%) • intestinal perforation (1-4%) • severe toxemia

  20. Laboratory findings Routine examinations: • White blood cell count is normal or decreased. • Leukocytopenia

  21. Bacteriological examinations: • Blood culture -mostly (up to 90%) patients have positive culture in the 1stweek, and only 50% by the 3rdweek. • The yield is much lower if patient has taken antibiotics prior to the test. • Stool culture is negative in the first week and becomes positive in 75%of patients in the 3rdweek. • Urine culture parallels stool culture.

  22. Widal test • "O" agglutinin antibody titer ≥1:80 and "H" ≥1:160 or "O" 4 times higher supports a diagnosis of typhoid fever. • "O" rises alone, not "H", early of the disease. • Only "H" positive, but "O" negative, often nonspecifically elevated by immunization or previous infections • Antibody level maybe lower when have used antibiotics early.

  23. Limitations of Widal test It is non specific and a positive test could be due to • Infection by other salmonellae (as the antigen used for the test is also shared by other salmonellae) • Recent vaccination for typhoid • Past typhoid (already treated)

  24. Enteric (Typhoid) Fever: Treatment • Prompt administration of appropriate antibiotic therapy prevents severe complications of enteric fever and results in a case-fatality rate of <1%. • The initial choice of antibiotics depends on the susceptibility of the S.Typhi and S.Paratyphi strains in the area of residence or travel.

  25. Rx…

  26. 1st line • • Ciprofoxacin: 500mg PO BID for 5-7days • • Ceftriaxone 1-2 gm IM or IV for 10 -14 days • Alternative • • Azithromycine 1 gm PO daily for 5 days • • Chloramphenicol 500 mg Po QID for 14 days • • Norfloxacin 400mg twice daily for 10 days

  27. 2.4 Rickettisial diseases: (Epidemic and Endemic Typhus) • Rickettisiae are small intracellular bacteria that are spread to man by arthropod vectors, namely human body lice, fleas, ticks & larval mites. • Epidemic Typhus (Louse born ): is caused by R.prowazekii and transmitted by human body louse (Pediculushumanuscorporis). • Endemic Typhus (Flea born) / Murine Typhus: is cause by R. thyphi which is transmitted by fleas.

  28. Pathophysiology • In man rickettsia multiply in the endothelial cells of capillaries • causing lesions in the skin, brain, lung, heart, kidneys and skeletal muscles. • causes thromboses and small hemorrhages. • However, tissue and organ injury is commonly due to increased vascular permeability with resulting edema, hypovolemia and organ ischemia.

  29. Clinical Features (epidemic typhus) • Incubation period of 1 week • Abrupt onset of illness with prostration, severe headache and rapidly rising fever of 38.8 to 40.0 °C • Cough s seen in 70 % of patients , myalgia may also occur which may be severe • Rash, begins on upper trunk around 5thday and then becomes generalized, involving the entire body except face, palms and soles; at first, rash is macular, becoming maculopapular, petechial and confluent without treatment, although in black people, rash may be absent (spotless epidemic typhus) • • Photophobia, with conjunctivalinfection and eye pain

  30. signs of central nervous system involvement,may occur at the end of 1stweek (meningo-encephalitis)

  31. Endemic typhus (Flea borne typhus) • Endemic typhus (also known as muri ne typhus) is a relatively milder. • The incubation period is 1 - 3 weeks and followed by sudden onset of fever, • rigors, frontal headache, pain in the back and limbs, constipation and cough (due to bronchitis). • The fever becomes constant after the third day and associated with conjunctivitis and orbital pain.

  32. Laboratory investigations; • Serologic tests: • • Indirect fluorescent antibody test • • Weil-Felix agglutination test: nonspecific or sensitive • Isolation of the organism by inoculation into laboratory animals

  33. Complications of Endemic and Epidemic Typhus • Skin necrosis, gangrene of digits, • Venous thrombosis • Interstitial pneumonia in severe cases • Myocarditis • Oliguric renal failure • Parotitis

  34. Treatment of rickettsial diseases • Endemic Typhus • Doxycycline 100mg bid PO for 7-15 days • Chloramphenicol 500mg QID PO for7-15 days • Epidemic typhus • Doxycycline 200mg as single dose PO until the patient is afebrile for 24 hours. • Delousing louse borne typhus

  35. Relapsing Fever • Definition • Relapsing fever is an acute febrile illness caused by Borrelia species, presenting with recurrence of characteristic febrile periods last ing for days alternating with afebrile periods. • Relapsing fever describes two distinct diseases: • • Louse borne (Endemic) relapsing fever (LBRF):- transmitted by body louse( Pediculushumanisvarcorporis) • • Tick borne (Epidemic) relapsing fever (TBRF)- transmitted by tick (Ornithodoros)

  36. Etiology • Relapsing fever is caused by Borrelia species, which are spirochetal gram negative helical bacteria. • B. recurrentis is the only species that cause LBRF • B. duttoni is the commonest causes of TBRF in sub-Saharan Africa

  37. PATHOGENESIS Portal of entry, infected lice crushed into abraded skin. Incubation period, 5-10 days. High level spirochetemia. Patients’ producing neutralizing antibodies, clearing of the circulating strain Borrelia in 3-5 days New ANTIGENIC VARIANTS appear Recurrence of clinical symptom/signs; up to 3-5 relapses may occur .

  38. CLINICAL FEATURES Incubation period, 5-10 days, average 7 days. The range of clinical symptoms/ signs is wide. In a typical sever case there is abrupt onset of fever, 39-40. The following is the dominant clinical features:

  39. CLINICAL FEATURES, contd. SIGNS • Temperature • Tachycardia • Hepatomegaly • Splenomegaly • Petichea/ Subconjunctival bleeding • Jaundice • Confusion/Meningism SYMPTOMS • Fever • Headaches • Arthralgia/myalgia • Dry cough • Epistaxis/gum bleeding

  40. COMPLICATIONS Congestive heart failure Jaundice Bleeding diathesis Jarish- Herxheimer reaction: The first dose of appropriate antibiotic causes transient worsening of clinical symptoms/signs. Frequency, 35-100%, associated with increased mortality.

  41. COMPLICATIONS contd. Physiologic change: chills phase, rise in BP, pulse,and respiratory rate; flush phase, BP falls dramatically . There is a marked, but transient rise in circulating level of : TNF, IL-6, and IL-8 at the peak of the reaction (figure 2). DIAGNOSIS Demonstration of the organism; blood film.

  42. MANAGEMENT Aims of Management: Clinical cure Prevention of relapse Prevention/treatment of complications Antibiotic treatment: A number of antibiotics are effective: Anticipate the occurrence of Jarish- Herxheimer like reaction. In our setting we simply start with procaine penicillin 400,000IU IM and then observe for 12 hours and repeat blood film.

  43. Management of complications Supportive treatment: IV fluids for hypotension, diuretics for pulmonary edema. Prevention and control Better housing, reliable water supply, good personal hygiene. Insecticides like DDT for killing lice.

  44. Malaria

  45. Defn: Is a protozoan disease transmitted by the bite of A. mosquito • Transmission in 107 countries • Affect 3 billion ppls worldwide

  46. Etology • Four sp. Of the genus Plasmodium • Others – rare • P. falciparum – malignant malaria • P. vivax – tertian malaria • P. ovale – Tertian malaria • P. malariae – quartian malaria • NB: almost all deaths are caused by falciparum malaria

  47. Epidemology • Is complex and varies considerably even within relatively small geographic area • Endemicity: defined interms of parasitemia rates or palpable spleen rates in childern 2 – 9 yrs of age as • Hypoendemic - < 10% • Mesoendemic – 11 – 50% • Hyperendemic – 51 – 75% • Holoendemic - > 75%

  48. Epidemology • Stable transmission – is constant frequent round infection • Unstable transmission • transmission is low, erratic or focal • Full protective immunity is not acquired • Symptomatic disease occurs at all ages • Usually occurs in hypoendemic area

  49. Epidemology • Principal determinants are • The density of the vector • Human biting habit • Life span of A. mosquito • Common in both low and highland and epidemics is commonly observed in highlands • Temprature – < 16 -18 oc sporogony is inhibted

More Related